Skip to content

Vidian neurectomy for management of chronic cluster headache

Surgical role of vidian neurectomy in treating chronic cluster headache

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15975015
Enrollment
9
Registered
2017-05-23
Start date
2013-03-01
Completion date
Unknown
Last updated
2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic cluster headache Nervous System Diseases Chronic cluster headache

Interventions

All participants undergo a trans-nasal endoscopic vidian neurectomy with maximal preservation of spheno-palatine ganglion activity. This involves precisely nerve transect via an endoscopic trans-naasl

Sponsors

Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of CCH according to the criteria of International Classification of Headache Disorders 2nd edition (ICHD-II) 2. Duration of CH exceeding three years 3. Daily attacks 4. Resistance to more than two pharmacological prophylactic treatments with adequate trials including rizatriptan or other available drugs in Taiwan (verapamil, lithium or steroid) 5. Treatment by vidian neurectomy ranked as a precise cut, with follow-up exceeding one year 6. Aged 17 years and over

Exclusion criteria

Exclusion criteria: Patients with cluster headache who show good response to pharmacological treatments.

Design outcomes

Primary

MeasureTime frame
Headache pattern is measured by patient interviews, to obtain the change of the mean attack frequency (numbers of attacks per week) and mean attack intensity (using the visual analogue scale (VAS)) at baseline, one week, and one, three, six and twelve months post procedure.

Secondary

MeasureTime frame
The degree participants’ daily lives disrupted by cluster headache is obtained by patient interviews and questionnaire: the pain disability index (PDI) at baseline, one week, and one, three, six and twelve months post procedure.

Countries

Taiwan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026